Cargando…
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
The syndrome of heart failure (HF) has historically been dichotomized based on clinical trial inclusion criteria into patients with a reduced or preserved left ventricular ejection fraction (LVEF) using a cut-off of above or below 40%. The majority of trial evidence for the benefits of disease-modif...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762881/ https://www.ncbi.nlm.nih.gov/pubmed/36545228 http://dx.doi.org/10.1093/eurheartjsupp/suac113 |